Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Evening primrose oil 0.87% cream
130201000AACYCY
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Evenity 105mg/1.17ml solution for injection pre-filled pens
0606020AABBAAAA
|
Evenity | Romosozumab | Endocrine System | No data available |
|
Everfresh 100% organic rye sourdough bread unsliced
0904010U0BXACAA
|
Everfresh (Gluten free bread) | Gluten free/wheat free bread | Nutrition and Blood | No data available |
|
Everfresh gluten free mixed grain sourdough bread
0904010H0CJAAAA
|
Everfresh (G/F Bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Everfresh organic rye bread with poppy seeds unsliced
0904010U0BXABAA
|
Everfresh (Gluten free bread) | Gluten free/wheat free bread | Nutrition and Blood | No data available |
|
Everfresh organic rye bread with sunflower seeds unsliced
0904010U0BXADAA
|
Everfresh (Gluten free bread) | Gluten free/wheat free bread | Nutrition and Blood | No data available |
|
Everolimus 10mg tablets
0801050AXAAABAB
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 2.5mg tablets
0801050AXAAACAC
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 2mg dispersible tablets sugar free
0801050AXAAAGAG
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 3mg dispersible tablets sugar free
0801050AXAAAHAH
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 500microgram tablets
0801050AXAAAFAF
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everolimus 5mg dispersible tablets sugar free
0801050AXAAAIAI
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Everose 660mg tablets
0905022C0BEAAAG
|
Everose | Calcium acetate | Nutrition and Blood | No data available |
|
Every x 3 testing discs
0601060D0CQAAA0
|
Every (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Eviplera 200mg/25mg/245mg tablets
050301000BBABA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | No data available |
|
Evirex 60mg tablets
0604011X0BFAAAA
|
Evirex | Raloxifene hydrochloride | Endocrine System | No data available |
|
Evolocumab 140mg/1ml inj pre-filled syringes
0212000AHAAABAB
|
Evolocumab | Evolocumab | Cardiovascular System | No data available |
|
Evoltra 20mg/20ml concentrate for inf vials
0801030AABBAAAA
|
Evoltra | Clofarabine | Malignant Disease and Immunosuppression | No data available |
|
Evolve Plus emollient spray
21220000208
|
Evolve Plus emollient spray | Emollients | Appliances | No data available |
|
Evorel Pak
0604011L0BHAAAJ
|
Evorel (with Progestogen) | Estradiol with progestogen | Endocrine System | No data available |
|
Evotaz 300mg/150mg tablets
0503010ALBBAAAA
|
Evotaz | Atazanavir and cobicistat | Infections | No data available |
|
Evotrox 100micrograms/5ml oral solution
0602010V0BHACGB
|
Evotrox | Levothyroxine sodium | Endocrine System | No data available |
|
Evotrox 25micrograms/5ml oral solution
0602010V0BHAAFZ
|
Evotrox | Levothyroxine sodium | Endocrine System | No data available |
|
Evoxil 250mg tablets
0501120X0BCAAAB
|
Evoxil | Levofloxacin | Infections | No data available |
|
Evoxil 500mg tablets
0501120X0BCACAA
|
Evoxil | Levofloxacin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.